Schrodinger SDGR Drug discovery — Timing of revenue recognition

Similar metrics at other companies

CDNSRevenue from contract with customer, timing of goods or service

100%0.0pp

CWContract revenue recognition

$13.3M-12.8%

ZYMERecognition of deferred revenue — Research and development collaborations (note 11)

$0—

ESESoftware Contract — Percentage Of Revenues Recognized When Services Are Performed For Unaffiliated Customers Or When Products Are Delivered At Point Of Time

0.5%0.0pp

VCYTBiopharmaceutical and other revenue — Deferred Revenue

$700K-58.8%

AJGRevenue recognition

$124M—

Questions, answered.

What is Schrodinger's drug discovery — timing of revenue recognition?

Schrodinger (SDGR) reported drug discovery — timing of revenue recognition of 39.1% in Q1 2026.

How has Schrodinger's drug discovery — timing of revenue recognition changed year-over-year?

Schrodinger's drug discovery — timing of revenue recognition increased by 158.9% year-over-year, from 15.1% to 39.1%.

What does drug discovery — timing of revenue recognition mean?

This represents the accounting methodology and schedule by which revenue is realized from long-term research contracts. It provides insight into the predictability and volatility of cash flows based on project milestones and service delivery phases.